Paper · 2026 · Open access

Effects of Anti-inflammatory on Neurodegenerative disorder

Neelam Balekar Garima Sharma*

Zenodo (CERN European Organization for Nuclear Research) · Published 20 August 2026 · DOI 10.5281/zenodo.22031432

Read the free full textCite this paper

In brief

“Effects of Anti-inflammatory on Neurodegenerative disorder” is a 2026 paper by Neelam Balekar Garima Sharma*, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).

Citations
0
Authors
1

Abstract

Elderly populations are expected to increase, leading to an increase in neurodegenerative diseases such as Alzheimer's Disease (AD), Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Huntington's Disease (HD). The role of neuroinflammation in the onset and progression of these diseases is becoming increasingly apparent. There are numerous studies demonstrating that, following chronic activation of microglia and astrocytes, pro-inflammatory cytokine release occurs at excessive levels, oxidative stress and mitochondrial dysfunction are present, and pathological proteins aggregate and lead to progressive neuronal death. The NLRP3 inflammasome plays an important role as a link between innate immune activation and synaptic dysfunction and neuronal apoptosis. This article examines the therapeutic potential of various strategies to manage neurodegenerative diseases through reducing inflammation in the central nervous system. These strategies may include using non-steroidal anti-inflammatory drugs (NSAIDs), COX-2-selective inhibitors, tetracycline derivatives, therapies aimed at inhibiting the NLRP3 inflammasome, and antioxidant-based therapies. Preclinical research shows that these agents have the ability to reduce microglial activation, cytokine release, oxidative damage to neurons, and promote neuron survival. However, clinical results have been inconsistent due to the complexity of these diseases, the variability of individual inflammatory responses, variability in blood-brain barrier permeability, issues of safety, and the time of intervention. New research is focusing on identifying neuroinflammatory biomarkers as well as exploring the use of selective immunomodulator therapy, combination therapy, and precision medicine with the ultimate goal of developing effective disease-modifying therapies through a better understanding of the interactions between neuroimmune systems.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sharma*, N. B. G. (2026). Effects of Anti-inflammatory on Neurodegenerative disorder. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.22031432

MLA 9

Sharma*, Neelam Balekar Garima. “Effects of Anti-inflammatory on Neurodegenerative disorder.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.22031432.

Chicago

Sharma*, Neelam Balekar Garima. 2026. “Effects of Anti-inflammatory on Neurodegenerative disorder.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.22031432.

Harvard

Sharma*, N. B. G. (2026) ‘Effects of Anti-inflammatory on Neurodegenerative disorder’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.22031432.

IEEE

N. B. G. Sharma*, “Effects of Anti-inflammatory on Neurodegenerative disorder,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.22031432.

BibTeX

@article{sharma2026effects,
  title     = {{Effects of Anti-inflammatory on Neurodegenerative disorder}},
  author    = {Sharma*, Neelam Balekar Garima},
  journal   = {Zenodo (CERN European Organization for Nuclear Research)},
  year      = {2026},
  doi       = {10.5281/zenodo.22031432},
  url       = {https://doi.org/10.5281/zenodo.22031432}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms

  • neuroinflammation
  • neurodegenerative diseases
  • anti-inflammatory therapy
  • Alzheimer's disease
  • Parkinson's disease
  • amyotrophic lateral sclerosis
  • Huntington's disease
  • microglial activation

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Sharma*, N. B. G. (2026). Effects of Anti-inflammatory on Neurodegenerative disorder. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.22031432

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).

Who wrote this paper?

Neelam Balekar Garima Sharma*.

What is the DOI of this paper?

10.5281/zenodo.22031432. The permanent link is https://doi.org/10.5281/zenodo.22031432.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.